Spinal Cord Research Help
AboutCategoriesLatest ResearchContact
Subscribe
Spinal Cord Research Help

Making Spinal Cord Injury (SCI) Research Accessible to Everyone. Simplified summaries of the latest research, designed for patients, caregivers and anybody who's interested.

Quick Links

  • Home
  • About
  • Categories
  • Latest Research
  • Disclaimer

Contact

  • Contact Us
© 2025 Spinal Cord Research Help

All rights reserved.

  1. Home
  2. Research
  3. Neurology
  4. Systemic inflammation associates with and precedes cord atrophy in progressive multiple sclerosis

Systemic inflammation associates with and precedes cord atrophy in progressive multiple sclerosis

BRAIN COMMUNICATIONS, 2024 · DOI: https://doi.org/10.1093/braincomms/fcae143 · Published: April 20, 2024

NeurologyGenetics

Simple Explanation

This study investigated the relationship between systemic inflammation and the progression of multiple sclerosis (MS), specifically focusing on brain and spinal cord atrophy. Systemic inflammation was measured using urinary neopterin levels, and MRI was used to assess brain and cervical spinal cord atrophy over a 2.5-year period. The study found that systemic inflammation was associated with cervical cord atrophy, suggesting that inflammation outside the central nervous system may contribute to the progression of disability in MS.

Study Duration
2.5 years
Participants
50 people with progressive multiple sclerosis
Evidence Level
Longitudinal cohort observational study

Key Findings

  • 1
    Systemic inflammation, measured by urinary neopterin levels, predicts cervical cord atrophy in individuals with progressive MS.
  • 2
    The association between the inflammatory response and cord atrophy depends on the level of background inflammation, suggesting a preconditioning effect.
  • 3
    A time lag exists between systemic inflammation and cord atrophy, supporting the hypothesis that systemic inflammation contributes to the progression of MS.

Research Summary

This longitudinal study assessed the relationship between systemic inflammation and CNS atrophy in individuals with progressive MS over 2.5 years. The findings indicate that systemic inflammation associates with and precedes multiple sclerosis progression, specifically cervical cord atrophy. The study suggests that targeting systemic inflammation may offer novel treatment strategies for slowing neurodegeneration in multiple sclerosis.

Practical Implications

Therapeutic Target

Systemic inflammation may be a potential therapeutic target for slowing neurodegeneration in MS.

Monitoring Tool

Urinary neopterin-to-creatinine ratio (UNCR) can be used to monitor systemic inflammation in longitudinal studies.

Further Research

Further research is needed to prove causation and to explore the underlying biology of the relationship between systemic inflammation and MS progression.

Study Limitations

  • 1
    Causation not proven
  • 2
    Reliance on imaging at only two timepoints
  • 3
    Neopterin is more representative of a Th1-type immune response

Your Feedback

Was this summary helpful?

Back to Neurology